Page last updated: 2024-12-06

methoxygramine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID27965
CHEMBL ID3769622
SCHEMBL ID1196012
MeSH IDM0052226

Synonyms (51)

Synonym
nsc-88885
5-methoxy-3-[(dimethylamino)methyl]indole
16620-52-3
indole, 3-[(dimethylamino)methyl]-5-methoxy-
nsc88885
wln: t56 bmj d1n1&1 go1
5-methoxygramine
3-[(dimethylamino)methyl]-5-methoxyindole
SDCCGMLS-0065813.P001
3-(dimethylaminomethyl)-5-methoxyindole
2-dimethylaminomethyl-5-methoxyindole
methoxygramine
1h-indole-3-methanamine, 5-methoxy-n,n-dimethyl-
einecs 240-669-8
indole, 3-((dimethylamino)methyl)-5-methoxy-
5-methoxy-3-(dimethylaminomethyl)indole
brn 0170533
nsc 88885
OPREA1_614357
5-methoxygramine, 99%
M-3400
HMS1661A01
1-(5-methoxy-1h-indol-3-yl)-n,n-dimethylmethanamine
3-dimethylaminomethyl-5-methoxyindole
j6zn008ry8 ,
5-22-12-00008 (beilstein handbook reference)
unii-j6zn008ry8
AKOS005202959
STL220640
n-[(5-methoxy-1h-indol-3-yl)methyl]-n,n-dimethylamine
FT-0620567
SCHEMBL1196012
5-methoxy gramine
(5-methoxy-1h-indol-3-yl)-n,n-dimethylmethanamine #
3-((dimethylamino)methyl)-5-methoxyindole
5-methoxy-3-((dimethylamino)methyl)indole
DTXSID30168081
CHEMBL3769622
mfcd00005630
CCG-235466
7zc ,
1-(5-methoxy-1h-indol-3-yl)-n,n-dimethyl-methanamine
SR-01000003310-1
sr-01000003310
5-methoxy-n,n-dimethyl-1h-indole-3-methanamine
AMY25941
AS-76881
CS-0214833
[(5-methoxy-1h-indol-3-yl)methyl]dimethylamine
EN300-197563
E83698
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (14.29)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's4 (57.14)24.3611
2020's1 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.39

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.39 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.46 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.39)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]